BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1131 related articles for article (PubMed ID: 27581457)

  • 41. Cholinergic Transmission at Muscarinic Synapses in the Striatum Is Driven Equally by Cortical and Thalamic Inputs.
    Mamaligas AA; Barcomb K; Ford CP
    Cell Rep; 2019 Jul; 28(4):1003-1014.e3. PubMed ID: 31340139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optogenetic Globus Pallidus Stimulation Improves Motor Deficits in 6-Hydroxydopamine-Lesioned Mouse Model of Parkinson's Disease.
    Di Bisceglie Caballero S; Ces A; Liberge M; Ambroggi F; Amalric M; Ouagazzal AM
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Striatal cholinergic interneurons and Parkinson's disease.
    Tanimura A; Pancani T; Lim SAO; Tubert C; Melendez AE; Shen W; Surmeier DJ
    Eur J Neurosci; 2018 May; 47(10):1148-1158. PubMed ID: 28677242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease.
    Bagetta V; Picconi B; Marinucci S; Sgobio C; Pendolino V; Ghiglieri V; Fusco FR; Giampà C; Calabresi P
    J Neurosci; 2011 Aug; 31(35):12513-22. PubMed ID: 21880913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective remodeling of glutamatergic transmission to striatal cholinergic interneurons after dopamine depletion.
    Aceves Buendia JJ; Tiroshi L; Chiu WH; Goldberg JA
    Eur J Neurosci; 2019 Mar; 49(6):824-833. PubMed ID: 28922504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA.
    Sciamanna G; Hollis R; Ball C; Martella G; Tassone A; Marshall A; Parsons D; Li X; Yokoi F; Zhang L; Li Y; Pisani A; Standaert DG
    Neurobiol Dis; 2012 Sep; 47(3):416-27. PubMed ID: 22579992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of dopamine D1 receptor-mediated ERK1/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5.
    Fieblinger T; Sebastianutto I; Alcacer C; Bimpisidis Z; Maslava N; Sandberg S; Engblom D; Cenci MA
    J Neurosci; 2014 Mar; 34(13):4728-40. PubMed ID: 24672017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons.
    Sciamanna G; Napolitano F; Pelosi B; Bonsi P; Vitucci D; Nuzzo T; Punzo D; Ghiglieri V; Ponterio G; Pasqualetti M; Pisani A; Usiello A
    Neurobiol Dis; 2015 Jun; 78():146-61. PubMed ID: 25818655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors.
    Jeon J; Dencker D; Wörtwein G; Woldbye DP; Cui Y; Davis AA; Levey AI; Schütz G; Sager TN; Mørk A; Li C; Deng CX; Fink-Jensen A; Wess J
    J Neurosci; 2010 Feb; 30(6):2396-405. PubMed ID: 20147565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced mu opioid receptor-dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia.
    Ponterio G; Tassone A; Sciamanna G; Vanni V; Meringolo M; Santoro M; Mercuri NB; Bonsi P; Pisani A
    Mov Disord; 2018 Feb; 33(2):310-320. PubMed ID: 29150865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Knockouts reveal overlapping functions of M(2) and M(4) muscarinic receptors and evidence for a local glutamatergic circuit within the laterodorsal tegmental nucleus.
    Kohlmeier KA; Ishibashi M; Wess J; Bickford ME; Leonard CS
    J Neurophysiol; 2012 Nov; 108(10):2751-66. PubMed ID: 22956788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new outlook on cholinergic interneurons in Parkinson's disease and L-DOPA-induced dyskinesia.
    Conti MM; Chambers N; Bishop C
    Neurosci Biobehav Rev; 2018 Sep; 92():67-82. PubMed ID: 29782883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The vesamicol receptor ligand (+)-meta-[125I]iodobenzyltrozamicol [(+)-[125I]-MIBT] reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: possible implications for Parkinson's disease.
    Efange SM; Langason RB; Khare AB; Low WC
    Life Sci; 1996; 58(16):1367-74. PubMed ID: 8614294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
    Pinna A; Tronci E; Schintu N; Simola N; Volpini R; Pontis S; Cristalli G; Morelli M
    Neuropharmacology; 2010 Mar; 58(3):613-23. PubMed ID: 19951715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice.
    Volpicelli-Daley LA; Hrabovska A; Duysen EG; Ferguson SM; Blakely RD; Lockridge O; Levey AI
    Mol Pharmacol; 2003 Dec; 64(6):1309-16. PubMed ID: 14645660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complex Movement Control in a Rat Model of Parkinsonian Falls: Bidirectional Control by Striatal Cholinergic Interneurons.
    Avila C; Kucinski A; Sarter M
    J Neurosci; 2020 Jul; 40(31):6049-6067. PubMed ID: 32554512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice.
    Ding Y; Won L; Britt JP; Lim SA; McGehee DS; Kang UJ
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):840-5. PubMed ID: 21187382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cholinergic interneuron inhibition potentiates corticostriatal transmission in direct medium spiny neurons and rescues motor learning in parkinsonism.
    Laverne G; Pesce J; Reynders A; Combrisson E; Gascon E; Melon C; Kerkerian-Le Goff L; Maurice N; Beurrier C
    Cell Rep; 2022 Jul; 40(1):111034. PubMed ID: 35793632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optogenetic stimulation of cortico-subthalamic projections is sufficient to ameliorate bradykinesia in 6-ohda lesioned mice.
    Sanders TH; Jaeger D
    Neurobiol Dis; 2016 Nov; 95():225-37. PubMed ID: 27452483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry.
    Kravitz AV; Freeze BS; Parker PR; Kay K; Thwin MT; Deisseroth K; Kreitzer AC
    Nature; 2010 Jul; 466(7306):622-6. PubMed ID: 20613723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.